Am. J. Respir. Crit. Care Med., Volume 165, Number 6, March 2002, 812-817

Limited Transmission of Multidrug-Resistant Tuberculosis Despite a High Proportion of Infectious Cases in Los Angeles County, California

ANNETTE T. NITTA, LAURA S. KNOWLES, JAIMIN KIM, ELEANOR L. LEHNKERING, LEE A. BORENSTEIN, PAUL T. DAVIDSON, SYDNEY M. HARVEY, and MURIEL L. DE KONING

Tuberculosis Control Program, Public Health, Los Angeles County Department of Health Services; University of California, Los Angeles, School of Medicine or Public Health; Public Health Laboratory, Los Angeles County Department of Health Services; and University of Southern California, School of Medicine, Los Angeles, California

Preventing transmission of multidrug-resistant tuberculosis is critical because of treatment toxicity, cost, and the lack of effective therapy for latent infection. We attempted to determine the extent of transmission in Los Angeles County by comparing relatedness of multidrug-resistant tuberculosis cases using restriction fragment length polymorphism and by cross-matching contact information to the Tuberculosis Registry. Strain typing was done on isolates of 102 pulmonary multidrug-resistant cases identified between August 1993 and 1998. Seventy-one (70%) of the cases had cavitary lesions on chest radiograph, and 94 (92%) had sputa smear-positive for acid fast bacilli. Fifteen (15%) of the cases were known to be infected with human immunodeficiency virus. Four molecular clusters of two cases each and one closely related pair were identified among the 102 cases; contact investigation successfully identified all clusters but one. Among 946 contacts identified and cross-matched with the county's Tuberculosis Registry, one secondary case due to drug-resistant Mycobacterium bovis was found. To summarize, a very high proportion of pulmonary multidrug-resistant tuberculosis cases in Los Angeles County were infectious. Molecular strain typing indicated limited spread of disease, although it underestimated transmission compared with contact investigation. We believe aggressive surveillance and case management were critical to limiting the spread of multidrug- resistant tuberculosis.

This article has been cited by other articles:

				B. Romero, A. Aranaz, L. d. Juan, J. Alvarez, J. Bezos, A. Mateos, E. Gomez-Mampaso, and L. Dominguez Molecular Epidemiology of Multidrug-Resistant Mycobacterium bovis Isolates with the Same Spoligotyping Profile as Isolates from Animals. J. Clin. Microbiol., September 1, 2006; 44(9): 3405 - 3408. [Abstract] [Full Text] [PDF]

				G. Mixides, V. Shende, L. D. Teeter, R. Awe, J. M. Musser, and E. A. Graviss Number of Negative Acid-Fast Smears Needed To Adequately Assess Infectivity of Patients With Pulmonary Tuberculosis Chest, July 1, 2005; 128(1): 108 - 115. [Abstract] [Full Text] [PDF]

				S. Samper, M. J. Iglesias, M. J. Rabanaque, L. I. Gomez, M. C. Lafoz, M. S. Jimenez, A. Ortega, M. A Lezcano, D. Van Soolingen, C. Martin, et al. Systematic Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates from Spain J. Clin. Microbiol., March 1, 2005; 43(3): 1220 - 1227. [Abstract] [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355. [Full Text] [PDF]

				P. Spradling, R. Ridzon, A. T. Nitta, and J. Kim Limited transmission of multidrug-resistant tuberculosis Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 473 - 474. [Full Text] [PDF]

				U. R. Dahle, P. Sandven, E. Heldal, T. Mannsaaker, and D. A. Caugant Deciphering an Outbreak of Drug-Resistant Mycobacterium tuberculosis J. Clin. Microbiol., January 1, 2003; 41(1): 67 - 72. [Abstract] [Full Text] [PDF]

				C. L. Daley Transmission of Multidrug-Resistant Tuberculosis . Limited by Man or Nature? Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 742 - 743. [Full Text] [PDF]